We applied the DeMixT deconvolution pipeline to the expression arrays of the combined discovery and validation sets, after batch effect correction, to estimate tumor-specific proportions using the adjacent normal samples as the reference. Affymetrix CEL files were processed by PennCNV87 (link) to obtain the LogR and B allele frequency (BAF) data, followed by both ASCAT32 (link) and Sequenza49 (link) to estimate tumor purity and ploidy for each sample. The consensus TmS strategy was applied to obtain robust TmS estimations. In total, 1,664 patient samples with TmS remained after the above steps. We additionally removed 118 patient samples due to missing follow-up information of biochemical recurrence intervals or the PAM50 subtypes. A final cohort of 1,546 patient samples from both the discovery and validation sets was kept for downstream analyses. See Supplementary Notes
Tumor Purity and Ploidy Estimation
We applied the DeMixT deconvolution pipeline to the expression arrays of the combined discovery and validation sets, after batch effect correction, to estimate tumor-specific proportions using the adjacent normal samples as the reference. Affymetrix CEL files were processed by PennCNV87 (link) to obtain the LogR and B allele frequency (BAF) data, followed by both ASCAT32 (link) and Sequenza49 (link) to estimate tumor purity and ploidy for each sample. The consensus TmS strategy was applied to obtain robust TmS estimations. In total, 1,664 patient samples with TmS remained after the above steps. We additionally removed 118 patient samples due to missing follow-up information of biochemical recurrence intervals or the PAM50 subtypes. A final cohort of 1,546 patient samples from both the discovery and validation sets was kept for downstream analyses. See Supplementary Notes
Corresponding Organization :
Other organizations : The University of Texas MD Anderson Cancer Center, Oslo University Hospital, Tampere University Hospital, University of California, Los Angeles, University of Toronto, The Francis Crick Institute, Wellcome Sanger Institute, Walter and Eliza Hall Institute of Medical Research
Variable analysis
- Tumor-specific proportions estimated using the DeMixT deconvolution pipeline
- Tumor purity and ploidy estimated using ASCAT and Sequenza
- Biochemical recurrence intervals
- PAM50 subtypes
- Adjacent normal tissue samples used as reference for the DeMixT deconvolution pipeline
- Positive control: Adjacent normal tissue samples used as reference for the DeMixT deconvolution pipeline
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!